Shares of health-care companies fell amid fears of a government shutdown.
The health-care industry is among the most intertwined with Washington agencies, and President Donald Trump's threat of a shutdown could have profound ramifications for many health-care companies.
Continue Reading Below
Shares of Ultragenyx Pharmaceutical fell sharply after a rare-disease drug showed little promise in a late-stage clinical trial.
Medical-device maker Stryker is recalling certain Oral Care products sold between July 2015 and August 2017 after receiving reports of minor irritation and allergic reactions after use.
-Rob Curran, firstname.lastname@example.org
(END) Dow Jones Newswires
August 23, 2017 16:38 ET (20:38 GMT)